What seems obvious to me, yet no one is discussing it, is that the reason for the new accounting system is that the company's projected sales are flat and with this new system they would appear better. But the scary thing is that projected sales don't seem too good even with the new system. That's why a lot of stockholders are exiting.
The question I have is weather or not the Medical community has accepted Jakafi as a treatment for their patients or do we have to get a sales team together to educate. Looks to me like we need some good sales help and more patients on the drug at an earlier stage. Something is missing and only the staff knows what it is. Maybe the reason for the insider selling.